Endostatin (Bolder Biotechnology)

N/A

Report date: 2022/03/23 17:16:00

Base Information

Drug NameEndostatin (Bolder Biotechnology)
Drug Alias NameEndostatin analogues (Bolder Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBolder Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBolder Biotechnology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A